When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
INCY - Incyte launches pivotal study of Jakafi for COVID-19 complication
Incyte Corporation
Incyte (INCY+4.6%) initiates a Phase 3 clinical trial, RUXCOVID, evaluating Jakafi (ruxolitinib) plus standard-of-care treatment in COVID-19 patients at least 12 years old who are experiencing cytokine storm, a potentially life-threatening out-of-control immune response.
More news on: Incyte Corporation, Healthcare stocks news, Stocks on the move,